Detalhe da pesquisa
1.
Immunogenicity and Safety of a Purified Vero Rabies Vaccine-Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial.
Clin Infect Dis
; 78(6): 1748-1756, 2024 Jun 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38478634
2.
Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies.
Proc Natl Acad Sci U S A
; 115(24): 6273-6278, 2018 06 12.
Artigo
Inglês
| MEDLINE | ID: mdl-29686064
3.
Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia.
J Infect Dis
; 217(12): 1907-1917, 2018 05 25.
Artigo
Inglês
| MEDLINE | ID: mdl-29528415
4.
Safety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax® Rabies) administered in a simulated rabies post-exposure regimen in healthy adults.
Vaccine
; 42(10): 2553-2559, 2024 Apr 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38105138
5.
Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults.
Hum Vaccin Immunother
; 19(3): 2275453, 2023 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37921410
6.
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial.
Lancet
; 377(9773): 1256-63, 2011 Apr 09.
Artigo
Inglês
| MEDLINE | ID: mdl-21481708
7.
Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women.
J Infect Dis
; 203(11): 1534-41, 2011 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21592981
8.
Serum-free purified Vero rabies vaccine is safe and immunogenic in children: Results of a randomized phaseII pre-exposure prophylaxis regimen study.
Vaccine
; 40(35): 5170-5178, 2022 08 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35906106
9.
Safety and immunogenicity of a serum-free purified Vero rabies vaccine in healthy adults: A randomised phase II pre-exposure prophylaxis study.
Vaccine
; 40(33): 4780-4787, 2022 08 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35778281
10.
Seronegative patients vaccinated with cytomegalovirus gB-MF59 vaccine have evidence of neutralising antibody responses against gB early post-transplantation.
EBioMedicine
; 50: 45-54, 2019 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-31735553
11.
Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial.
Vaccine
; 34(3): 313-9, 2016 Jan 12.
Artigo
Inglês
| MEDLINE | ID: mdl-26657184
12.
A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab for pre-exposure use in healthy adults: results from a randomized controlled phase-II trial.
Vaccine
; 31(18): 2295-301, 2013 Apr 26.
Artigo
Inglês
| MEDLINE | ID: mdl-23510665
13.
A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in China.
Vaccine
; 31(50): 5940-7, 2013 Dec 05.
Artigo
Inglês
| MEDLINE | ID: mdl-24148575
14.
An adjuvanted, low-dose, pandemic influenza A (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults.
J Infect Dis
; 198(5): 642-9, 2008 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-18576945
15.
Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies.
Vaccine
; 21(25-26): 3730-3, 2003 Sep 08.
Artigo
Inglês
| MEDLINE | ID: mdl-12922104